Literature DB >> 21743918

Combined in situ XRD and in situ XANES studies on the reduction behavior of a rhenium promoted cobalt catalyst.

Nitin Kumar1, E A Payzant, K Jothimurugesan, J J Spivey.   

Abstract

A 10% Co-4% Re/(2% Zr/SiO(2)) catalyst was prepared by co-impregnation using a silica support modified by 2% Zr. The catalyst was characterized by temperature programmed reduction (TPR), in situ XRD and in situ XANES analysis where it was simultaneously exposed to H(2) using a temperature programmed ramp. The results showed the two step reduction of large crystalline Co(3)O(4) with CoO as an intermediate. TPR results showed that the reduction of highly dispersed Co(3)O(4) was facilitated by reduced rhenium by a H(2)-spillover mechanism. In situ XRD results showed the presence of both, Co-hcp and Co-fcc phases in the reduced catalyst at 400 °C. However, the Co-hcp phase was more abundant, which is thought to be the more active phase as compared to the Co-fcc phase for CO hydrogenation. CO hydrogenation at 270 °C and 5 bar pressure produces no detectable change in the phases during the time of experiment. In situ XANES results showed a decrease in the metallic cobalt in the presence of H(2)/CO, which can be attributed due to oxidation of the catalyst by reaction under these conditions.

Entities:  

Year:  2011        PMID: 21743918     DOI: 10.1039/c1cp20856j

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  2 in total

1.  Combined Operando X-ray Diffraction/Raman Spectroscopy of Catalytic Solids in the Laboratory: The Co/TiO2 Fischer-Tropsch Synthesis Catalyst Showcase.

Authors:  Korneel H Cats; Bert M Weckhuysen
Journal:  ChemCatChem       Date:  2016-03-15       Impact factor: 5.686

2.  Chemical imaging of Fischer-Tropsch catalysts under operating conditions.

Authors:  Stephen W T Price; David J Martin; Aaron D Parsons; Wojciech A Sławiński; Antonios Vamvakeros; Stephen J Keylock; Andrew M Beale; J Frederick W Mosselmans
Journal:  Sci Adv       Date:  2017-03-17       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.